Sol-Gel Technologies to Present in Upcoming H.C. Wainwright Global Investment Conference
Event: | |
Date: | |
Format: | On-demand presentation and 1:1 meetings |
Time: | Presentation available on-demand beginning |
Webcast: | Link |
About Sol-Gel Technologies
Sol-Gel is a dermatology company focused on identifying, developing and commercializing or partnering branded and generic topical drug products for the treatment of skin diseases.
The Company’s pipeline also includes early-stage topical drug candidates SGT-210, SGT-310 and SGT-510 under investigation for the treatment of plaque psoriasis and other dermatologic indications.
For further information, please contact:
Investors:
Investor relations,
[email protected]
+1 917 734 7387
Chief Financial Officer
[email protected]

Source: Sol-Gel Technologies Ltd.